| Product Code: ETC7551241 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India pleural effusion drug market import shipment exhibited robust growth with a notable CAGR from 2020 to 2024. However, there was a slight decline in growth rate between 2023 and 2024. Overall, the market demonstrated expansion, albeit with a slight slowdown towards the end of the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pleural Effusion Drug Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pleural Effusion Drug Market Revenues & Volume, 2021 & 2031F |
3.3 India Pleural Effusion Drug Market - Industry Life Cycle |
3.4 India Pleural Effusion Drug Market - Porter's Five Forces |
3.5 India Pleural Effusion Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Pleural Effusion Drug Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 India Pleural Effusion Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 India Pleural Effusion Drug Market Revenues & Volume Share, By Drug Class Type, 2021 & 2031F |
3.9 India Pleural Effusion Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 India Pleural Effusion Drug Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
4 India Pleural Effusion Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pleural effusion cases in India |
4.2.2 Growing awareness about treatment options for pleural effusion |
4.2.3 Technological advancements in drug development for pleural effusion |
4.3 Market Restraints |
4.3.1 High cost associated with pleural effusion drug treatment |
4.3.2 Limited access to healthcare facilities in rural areas of India |
4.3.3 Stringent regulatory requirements for drug approval in India |
5 India Pleural Effusion Drug Market Trends |
6 India Pleural Effusion Drug Market, By Types |
6.1 India Pleural Effusion Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Pleural Effusion Drug Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Pleural Effusion Drug Market Revenues & Volume, By Transudative Pleural Effusions, 2021- 2031F |
6.1.4 India Pleural Effusion Drug Market Revenues & Volume, By Exudative Effusions, 2021- 2031F |
6.2 India Pleural Effusion Drug Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 India Pleural Effusion Drug Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.3 India Pleural Effusion Drug Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.3 India Pleural Effusion Drug Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 India Pleural Effusion Drug Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 India Pleural Effusion Drug Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4 India Pleural Effusion Drug Market, By Drug Class Type |
6.4.1 Overview and Analysis |
6.4.2 India Pleural Effusion Drug Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.4.3 India Pleural Effusion Drug Market Revenues & Volume, By Sclerosing Agent, 2021- 2031F |
6.4.4 India Pleural Effusion Drug Market Revenues & Volume, By Diuretics, 2021- 2031F |
6.5 India Pleural Effusion Drug Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 India Pleural Effusion Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 India Pleural Effusion Drug Market Revenues & Volume, By Topical, 2021- 2031F |
6.6 India Pleural Effusion Drug Market, By End- Users |
6.6.1 Overview and Analysis |
6.6.2 India Pleural Effusion Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 India Pleural Effusion Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 India Pleural Effusion Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 India Pleural Effusion Drug Market Import-Export Trade Statistics |
7.1 India Pleural Effusion Drug Market Export to Major Countries |
7.2 India Pleural Effusion Drug Market Imports from Major Countries |
8 India Pleural Effusion Drug Market Key Performance Indicators |
8.1 Patient survival rate post drug treatment |
8.2 Percentage increase in the adoption of advanced drug therapies for pleural effusion |
8.3 Number of research and development initiatives focused on pleural effusion drug development |
8.4 Average waiting time for patients to access pleural effusion drug treatment |
8.5 Rate of adverse reactions reported for pleural effusion drugs |
9 India Pleural Effusion Drug Market - Opportunity Assessment |
9.1 India Pleural Effusion Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Pleural Effusion Drug Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 India Pleural Effusion Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 India Pleural Effusion Drug Market Opportunity Assessment, By Drug Class Type, 2021 & 2031F |
9.5 India Pleural Effusion Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 India Pleural Effusion Drug Market Opportunity Assessment, By End- Users, 2021 & 2031F |
10 India Pleural Effusion Drug Market - Competitive Landscape |
10.1 India Pleural Effusion Drug Market Revenue Share, By Companies, 2024 |
10.2 India Pleural Effusion Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here